BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
McKesson
Queensland Health
Boehringer Ingelheim
Mallinckrodt
US Department of Justice
Covington
McKinsey
Healthtrust
Johnson and Johnson

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,591,864

« Back to Dashboard

Which drugs does patent 8,591,864 protect, and when does it expire?

Patent 8,591,864 protects FERAHEME and is included in one NDA.

This patent has eleven patent family members in ten countries.
Summary for Patent: 8,591,864
Title:Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
Abstract: Iron oxide complexes, pharmacological compositions and unit dosage thereof, and methods for their administration, of the type employing an iron oxide complex with a polyol, are disclosed. The pharmacological compositions employ a polysaccharide iron oxide complex, wherein the polysaccharide is a modified polyol such as a carboxyalkylated reduced dextran. The complex is stable to terminal sterilization by autoclaving. The compositions are suitable for parenteral administration to a subject for the treatment of iron deficiencies or as MRI contrast agent. The complex is substantially immunosilent, provide minimal anaphylaxis and undergo minimal dissolution in vivo. The pharmacological compositions of the complex contain minimal free iron which can be quantified by a variety of methods.
Inventor(s): MAUSUSGroman; Ernest V. (Brookline, MA), Paul; Kenneth G. (Holliston, MA), Frigo; Timothy B. (Waltham, MA), Bengele; Howard (Canton, MA), Lewis; Jerome M. (Newton, MA)
Assignee: AMAG Pharmaceuticals, Inc. (Lexington, MA)
Application Number:13/734,339
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 8,591,864

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Amag Pharms Inc FERAHEME ferumoxytol SOLUTION;INTRAVENOUS 022180-001 Jun 30, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,591,864

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,926,947 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents ➤ Subscribe
6,599,498 Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives ➤ Subscribe
7,553,479 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof ➤ Subscribe
9,555,133 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents ➤ Subscribe
8,501,158 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents ➤ Subscribe
7,871,597 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,591,864

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Portugal 1169062 ➤ Subscribe
Luxembourg 92114 ➤ Subscribe
Japan 2011046752 ➤ Subscribe
Japan 5064612 ➤ Subscribe
Japan 2002541218 ➤ Subscribe
Spain 2334555 ➤ Subscribe
European Patent Office 1522318 ➤ Subscribe
European Patent Office 1169062 ➤ Subscribe C300558 Netherlands ➤ Subscribe
European Patent Office 1169062 ➤ Subscribe CA 2012 00050 Denmark ➤ Subscribe
European Patent Office 1169062 ➤ Subscribe 92114 Luxembourg ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
Mallinckrodt
Dow
Boehringer Ingelheim
Cantor Fitzgerald
Novartis
Express Scripts
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot